Rosemarie Truman is the President and CEO of RHT Consulting. Having worked for 18 years in strategy consulting, Rosemarie is in driving growth breakthrough innovation. While she has worked across industry sectors, most of her experience is in Life Sciences, High Tech, and Financial Services.
Having started her career at Goldman Sachs, she's been performing rigorous due diligence for the last 20 years. Recently, she created a provisional patent on a model for due diligence in Life Sciences.
Recent projects include creating a strategy, roadmap and blueprint for the National Institutes of Health Office of Technology Transfer; developing a portfolio strategy for Sequella as well as performing technology transfer benchmarking and developing recommendations for six Universities and two lar